Remodeling of the cardiovascular system in patients with essential arterial hypertension associated with primary subclinical hyperparathyroidism


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. One of the pathogenetic mechanisms of essential arterial hypertension (AH) is a genetically determined violation of the transmembrane transport of calcium ions in smooth muscle cells of resistance vessels. It is known that the parathyroid glands are among the main regulators of calcium metabolism in the body. Objective. Assessment of the structural and functional remodeling of the heart and blood vessels in the presence of primary subclinical hyperparathyroidism in patients with essential AH. Methods. A cross-sectional clinical study included 88 patients (51 men and 37 women) with uncomplicated/asymptomatic AH I-II degree. In the examined subjects, the blood parathyroid hormone (PTH) levels were in the reference range for age and ranged from 5 to 78 pg/mL. The patients were divided into 3 groups: in group 1 (28 patients) PTH levels ranged from 0 to 20 pg/mL, in group 2 (37 patients) - from 21 to 55 pg/mL, and in group 3 (23 patients) - from 56 pg/mL to the upper reference value. All patients underwent echocardiography and 24-hour blood pressure monitoring, and also determination of the flow-mediated vasodilation of the brachial artery and the daily calciuresis. Results. The detection rate of left ventricular (LV) hypertrophy in group 3 compared to group 1 was significantly higher: 65.2 versus 39.3% (p=0.036). In addition, the value of daily calciuresis, total and free blood calcium in the group 3 was significantly higher than in the group 1. The parameters of the LV myocardial mass index, the interventricular septum thickness and the LV posterior wall thickness in the group 3 significantly (p<0.05) exceeded those in the group 1. In the group 2 and 3, the most pronounced LV diastolic dysfunction was revealed. It was shown that the PTH level directly correlates with the thickness of the intima-media complex of the carotid artery (R=0.57; p<0.001) and the LV myocardial mass index (R=0.29; p=0.006), inversely - with the value of the endothelium-dependent vasodilation (R= -0.33; p=0.002). Conclusion. It was revealed that the blood PTH level, which is the 90th percentile of the reference range, correlates with signs of cardiac and vascular remodeling in patients with uncomplicated/asymptomatic essential AH.

Full Text

Restricted Access

About the authors

B. G Iskenderov

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

Email: iskenderovbg@mail.ru
Dr. Sci. (Med.), Prof. at the Department of Therapy, Cardiology, Functional Diagnostics and Rheumatology

N. V Berenshtein

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

I. N Mozhzhukhina

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

References

  1. Garda-Martfn A., Reyes-Garcia R., Garcia-Castro J.M., et al. Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism. Endocrinol Nutr. 2014;61:516-22. doi: 10.1016/j.endoen.2014.11.002
  2. Wilhelm S.M., Wang T.S., Ruan D.T., et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMASurg. 2016;151:959 68. doi: 10.1001/jamasurg.2016.2310
  3. Pepe J., Cipriani C., Sonato C., et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):R297-R308. doi: 10.1530/EJE-17-0485
  4. Дедов И.И., Мельниченко ГА., Мокрышева Н.Г. и др. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения. Проблемы эндокринологии. 2016;62(6):40-77. Doi: 10.14341/ probl201662640-77.
  5. Вороненко И.В., Мокрышева Н.Г., Рожинская Л.Я., Сыркин А.Л. Состояние сердечно-сосудистой системы при клинически выраженном и мало-симптомном первичном гиперпаратиреозе. Проблемы эндокринологии. 2009;55(3):17-22 doi: 10.14341/probl200955325-29.
  6. Fisher S.B., Perrier N.D. Primary hyperparathyroidism and hypertension. Gland Surg. 2020;9(1):142- 49. doi: 10.21037/gs.2019.10.21.
  7. Cansu G.B., Yilmaz N., Ozdem S., et al. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol. 2016;84:39-47. doi: 10.1111/cen.12952.
  8. Oinonen L., Koskela J., Eraranta A., et al. Plasma total calcium concentration is associated with blood pressure and systemic vascular resistance in normotensive and never-treated hypertensive subjects. Blood Pressure. 2020;29:137-48. doi: 10.1080/08037051.2019.1696180.
  9. Bosworth C., Sachs M.C., Duprez D., et al. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clinical Endocrinology 2013;79:429-36. Doi: 10.1111/ cen.12163.
  10. Assaad S.N., El-Aghoury A.A., El-Sharkawy E.M., et al. Parathormone is strongly related to left ventricular mass index in hypertensives, obese, and normal control. Alexandria J. Med. 2018;54(4):303-6. doi: 10.1016/j.ajme.2017.10.002.
  11. Verheyen N.D., Kienreich K., Gaksch M., et al. Plasma parathyroid hormone is independently related to nocturnal blood pressure in hypertensive patients: the Styrian Hypertension Study. J. Clin Hypertens (Greenwich). 2016;18:543-50. doi: 10.1111/jch.12710.
  12. Kalla A., Krishnamoorthy P., Gopalakrishnan A., et al. Primary hyperparathyroidism predicts hypertension: results from the National Inpatient Sample. Int J. Cardiol. 2017;227:335-37. doi: 10.1016/j.jcard.2016.11.080.
  13. Zhang Y., Zhang D.Z. Circulating parathyroid hormone and risk of hypertension: A metaanalysis. Clin Chim Acta. 2018;482:40-5.
  14. Gambardella J., De Rosa M., Sorriento D., et al. Parathyroid hormone causes endothelial dysfunction by inducing mitochondrial ROS and specific oxidative signal transduction modifications. Oxid Med Cell Longev. 2018;2018:9582319. doi: 10.1155/2018/9582319.
  15. Brown J.M., Williams J.S., Luther J.M., et al. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension. 2014;63:273-80. Doi: 10.1161/ HYPERTENSI0NAHA.113.01910.
  16. Tuna M.M., Dogan B.A., Arduc A., et al. Impaired endothelial function in patients with mild primary hyperparathyroidism improves after parathyroidectomy Clinical Endocrinol. 2015 83(6):951-56. Doi: 10.1111/ cen.12666.
  17. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российское кардиологическое общество. Российский кар диологический журнал. 2020;25(3):37-86. doi: 10.15829/1560-40712020-3-3786
  18. Walker M.D., Fleischer J.B., Di Tullio M.R. et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J. Clin Endocrinol Metab. 2010;95(5):2172-79. Doi: 10.1210/ jc.2009-2072.
  19. Beysel S., Caliskan M., Kizilgul M., et al. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19:106-13. Doi: 10.1186/ s12872-019-1093-4.
  20. Ejlsmark-Svensson H., Rolighed L., Rejnmark L. Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: a randomized clinical trial. J. Clin Endocrinol Metab. 2019;104:3223-32. doi: 10.1210/jc.2018-02456
  21. McMahon D.J., Carrelli A., Palmeri N., et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J. Clin Endocrinol Metab. 2015;100(12):439-4407. doi: 10.1210/jc.2015-3202.
  22. Magrina-Mercado R.M., Ramfrez-Renterfa C., Almeida-Gutierrez E., et al. Evaluation of endothelial function and diastolic function in patients with primary hyperparathyroidism before and after parathyroidectomy Cir Cir. 2019; 87(2):196-204.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies